Pre_GI: SWBIT SVG BLASTN

Query: NC_014532:2268078 Halomonas elongata DSM 2581, complete genome

Lineage: Halomonas elongata; Halomonas; Halomonadaceae; Oceanospirillales; Proteobacteria; Bacteria

General Information: Halomonas elongata DSM 2581 was isolated from a solar salt facility and is halotolerant up to a concentration of 35%. Halomonas elongata is a halophilic bacterium which uses ectoine as its major compatible solute. This organism can both, synthesize and degrade ectoine and is used as industrial ectoine producer.

- Sequence; - BLASTN hit (Low score = Light, High score = Dark)
- hypothetical protein; - cds: hover for description

BLASTN Alignment.txt

Subject: NC_011770:3735162 Pseudomonas aeruginosa LESB58, complete genome

Lineage: Pseudomonas aeruginosa; Pseudomonas; Pseudomonadaceae; Pseudomonadales; Proteobacteria; Bacteria

General Information: Pseudomonas aeruginosa LESB58 is a member of the Liverpool epidemic strains (LES) first isolated at the Liverpool Cystic Fibrosis (CF) clinic center. These isolates are highly virulent and readily transfered between CF patients and to non-CF individuals. Bacteria belonging to the Pseudomonas group are common inhabitants of soil and water and can also be found on the surfaces of plants and animals. Pseudomonas bacteria are found in nature in a biofilm or in planktonic form. Pseudomonas bacteria are renowned for their metabolic versatility as they can grow under a variety of growth conditions and do not need any organic growth factors. This organism is an opportunistic human pathogen. While it rarely infects healthy individuals, immunocompromised patients, like burn victims, AIDS-, cancer- or cystic fibrosis-patients are at increased risk for infection with this environmentally versatile bacteria. It is an important soil bacterium with a complex metabolism capable of degrading polycyclic aromatic hydrocarbons, and producing interesting, biologically active secondary metabolites including quinolones, rhamnolipids, lectins, hydrogen cyanide, and phenazines. Production of these products is likely controlled by complex regulatory networks making Pseudomonas aeruginosa adaptable both to free-living and pathogenic lifestyles. The bacterium is naturally resistant to many antibiotics and disinfectants, which makes it a difficult pathogen to treat.